INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,446,805 | -27.0% | 615,016 | -5.9% | 0.00% | -33.3% |
| Q2 2023 | $26,643,613 | +6.5% | 653,350 | -2.6% | 0.00% | 0.0% |
| Q1 2023 | $25,014,037 | +108092.2% | 671,132 | +1.3% | 0.00% | 0.0% |
| Q4 2022 | $23,120 | -99.9% | 662,617 | +3.4% | 0.00% | -40.0% |
| Q3 2022 | $35,862,000 | +7.8% | 640,847 | -0.3% | 0.01% | 0.0% |
| Q2 2022 | $33,253,000 | -27.1% | 642,464 | +2.3% | 0.01% | 0.0% |
| Q1 2022 | $45,635,000 | -42.3% | 627,969 | -6.0% | 0.01% | -44.4% |
| Q4 2021 | $79,028,000 | +19.3% | 668,367 | +35.4% | 0.01% | +12.5% |
| Q3 2021 | $66,234,000 | -54.4% | 493,727 | -44.9% | 0.01% | -52.9% |
| Q2 2021 | $145,164,000 | +100.5% | 896,577 | -0.6% | 0.02% | +70.0% |
| Q1 2021 | $72,385,000 | +115.4% | 901,934 | +46.0% | 0.01% | +100.0% |
| Q4 2020 | $33,610,000 | +263.2% | 617,824 | +44.3% | 0.01% | +150.0% |
| Q3 2020 | $9,254,000 | +41.9% | 428,196 | +38.0% | 0.00% | +100.0% |
| Q2 2020 | $6,522,000 | +138.5% | 310,281 | +38.8% | 0.00% | 0.0% |
| Q1 2020 | $2,735,000 | +48.2% | 223,622 | +77.7% | 0.00% | – |
| Q4 2019 | $1,846,000 | +992.3% | 125,815 | +892.6% | 0.00% | – |
| Q3 2019 | $169,000 | +11.2% | 12,675 | +26.8% | 0.00% | – |
| Q2 2019 | $152,000 | +10.1% | 10,000 | +23.4% | 0.00% | – |
| Q1 2019 | $138,000 | +19.0% | 8,106 | -4.5% | 0.00% | – |
| Q4 2018 | $116,000 | -47.3% | 8,487 | +10.3% | 0.00% | – |
| Q3 2018 | $220,000 | +18.9% | 7,695 | +14.0% | 0.00% | – |
| Q2 2018 | $185,000 | -68.5% | 6,748 | -75.8% | 0.00% | – |
| Q1 2018 | $588,000 | +752.2% | 27,884 | +675.6% | 0.00% | – |
| Q4 2017 | $69,000 | +46.8% | 3,595 | +8.9% | 0.00% | – |
| Q1 2017 | $47,000 | -96.4% | 3,302 | -94.6% | 0.00% | – |
| Q2 2016 | $1,301,000 | – | 60,925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |